• 30TH SEPTEMBER 2022

    Medicine Supply Notifiction: Dulaglutide (Trulicity® ) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection devices

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Dulaglutide (Trulicity®) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection devices. MSN/2022/079 Tier 2 – medium impact Date of issue 30th September 2022 Supplies of dulaglutide (Trulicity®) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection devices are limited until January 2023,

    Read more
    • 30TH SEPTEMBER 2022

    Amendment to notice periods required for changing supplementary hours

    Following discussions with the Department of Health and Social Care (DHSC) and NHS England as part of Year 4 negotiations, it has been agreed that the required notice periods for changes to supplementary opening hours will reduce. Community pharmacy contractors who want to change their supplementary opening hours are required by their terms of service

    Read more
    • 29TH SEPTEMBER 2022

    Flu vac: important reminder

    Contractors are reminded that they must ensure the correct flu vaccines are being used for each patient cohort within the NHS flu vaccination service. Please note, there is no provision for the use of standard egg-cultured quadrivalent influenza vaccine (QIVe) in the 65 years and over patient cohort. As set out in the reimbursement flu

    Read more
    • 29TH SEPTEMBER 2022

    NMS: Continued pause to NMS quarterly data reporting

    NHS England has confirmed, in its primary care bulletin, that community pharmacy contractors are not required to submit their completed New Medicine Service (NMS) quarterly summary data to the NHS Business Services Authority for July to September 2022 (Quarter 2), as this requirement has been postponed again. PSNC is pressing NHS England for a review of

    Read more
    • 29TH SEPTEMBER 2022

    111 online minor illness CPCS referrals to start on Monday

    From Monday 3rd October 2022, referrals from NHS 111 online to the Community Pharmacist Consultation Service (CPCS) will include those for minor illness consultations, as well as the current referrals received for urgent medicine supplies. This development of the 111 online system follows a six-month pilot across several areas, including Bristol, North Somerset and South

    Read more
    • 29TH SEPTEMBER 2022

    SCS: Guidance published for NHS trusts

    NHS England has published a practical guide for hospital tobacco dependence teams and hospital pharmacy teams on how to refer patients at discharge into the Smoking Cessation Service (SCS). Local Pharmaceutical Committees working with hospital trusts, community pharmacy contractors and pharmacists who are currently or intending to provide the service, may find the guidance helpful

    Read more
    • 29TH SEPTEMBER 2022

    September 2022 Price Concessions 4th Update

    The Department of Health and Social Care (DHSC) has today (29/09/2022) granted the following list of price concessions: Drug Pack size Price concession Amisulpride 400mg tablets 60 £46.00 Benzydamine 0.15% oromucosal spray sugar free 30 £3.47 Bisoprolol 2.5mg tablets 28 £0.85 Bumetanide 1mg/5ml oral solution sugar free 150 £235.00 Calamine lotion 200 £1.28 Chlorphenamine 2mg/5ml

    Read more
    • 28TH SEPTEMBER 2022

    Drug Tariff Watch – October 2022

    The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October 2022. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. § Selected

    Read more
    • 27TH SEPTEMBER 2022

    PSNC submits response on future of vacs services

    PSNC has submitted its response to NHS England’s market engagement on the future of vaccination services. The consultation is designed to help NHS England deliver a future vaccination strategy. It aims to support local teams that plan and deliver vaccinations to: build on the NHS COVID-19 vaccination programme’s success and learning; and provide responsive, accessible,

    Read more
    • 26TH SEPTEMBER 2022

    MHRA Drug Safety Update September 2022

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 2 September 2022) has been published and includes articles on: Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations Rucaparib (Rubraca▼): withdrawal of third-line treatment indication COVID-19 vaccines and medicines: updates for September 2022 Letters

    Read more